English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 6, 2026

Researchers report enzyme inhibition may protect against Parkinson’s neurodegeneration
+ Pharmaceuticals
Patient Daily | Jul 6, 2026

AI tool identifies new molecular signals linked to thrombosis risk, study reports
+ Pharmaceuticals
Patient Daily | Jul 6, 2026

Biotech leaders urge FDA to modernize regulatory approach amid shift of early trials overseas
+ Pharmaceuticals
Patient Daily | Jul 6, 2026

Study finds meat and dairy reductions may improve health and cut costs in Scotland
+ Pharmaceuticals
Patient Daily | Jul 6, 2026

Researchers compare continuous and 40-Hz light therapies in Alzheimer's disease mouse model
+ Pharmaceuticals
Patient Daily | Jul 6, 2026

Veradermics' stock rises 656% since IPO, driven by obesity market parallels
+ Pharmaceuticals
Patient Daily | Jul 6, 2026

FDA approves new therapy for double-positive metastatic breast cancer
+ Pharmaceuticals
Patient Daily | Jul 6, 2026

Case study highlights importance of accurate diagnosis in renal oncocytoma treatment

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation